A Novel Multimodal Nanoplatform for Targeting Tumor Necrosis

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2022 Apr 28

PMID 35479549

Authors

Xiangjun Han

Oleh Taratula

Anna St Lorenz

Abraham S Moses

Hassan A Albarqi

Younes Jahangiri

Qirun Wu

Ke Xu

Olena Taratula

Khashayar Farsad

Affiliations

Soon will be listed here.

Abstract

Peri-necrotic tumor regions have been found to be a source of cancer stem cells (CSC), important in tumor recurrence. Necrotic and peri-necrotic tumor zones have poor vascular supply, limiting effective exposure to systemically administered therapeutics. Therefore, there is a critical need to develop agents that can effectively target these relatively protected tumor areas. We have developed a multi-property nanoplatform with necrosis avidity, fluorescence imaging and X-ray tracking capabilities to evaluate its feasibility for therapeutic drug delivery. The developed nanoparticle consists of three elements: poly(ethylene glycol)--poly(ε-caprolactone) as the biodegradable carrier; hypericin as a natural compound with fluorescence and necrosis avidity; and gold nanoparticles for X-ray tracking. This reproducible nanoparticle has a hydrodynamic size of 103.9 ± 1.7 nm with a uniform spherical morphology (polydispersity index = 0.12). The nanoparticle shows safety with systemic administration and a stable 30 day profile. Intravenous nanoparticle injection into a subcutaneous tumor-bearing mouse and intra-arterial nanoparticle injection into rabbits bearing VX2 orthotopic liver tumors resulted in fluorescence and X-ray attenuation within the tumors. In addition, and histological analysis confirmed the accumulation of hypericin and gold in areas of necrosis and peri-necrosis. This nanoplatform, therefore, has the potential to enhance putative therapeutic drug delivery to necrotic and peri-necrotic areas, and may also have an application for monitoring early response to anti-tumor therapies.

References

Dani R, Schumann C, Taratula O, Taratula O . Temperature-tunable iron oxide nanoparticles for remote-controlled drug release. AAPS PharmSciTech. 2014; 15(4):963-72. PMC: 4113623. DOI: 10.1208/s12249-014-0131-x. View

Milross C, Tucker S, Mason K, Hunter N, Peters L, Milas L . The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncol. 1997; 36(2):183-9. DOI: 10.3109/02841869709109228. View

Jendzelovska Z, Jendzelovsky R, Kucharova B, Fedorocko P . Hypericin in the Light and in the Dark: Two Sides of the Same Coin. Front Plant Sci. 2016; 7:560. PMC: 4859072. DOI: 10.3389/fpls.2016.00560. View

Tong Y, Yang H, Xu X, Ruan J, Liang M, Wu J . Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion. Cancer Sci. 2017; 108(4):753-762. PMC: 5406608. DOI: 10.1111/cas.13191. View

Van de Putte M, Roskams T, Bormans G, Verbruggen A, de Witte P . The impact of aggregation on the biodistribution of hypericin. Int J Oncol. 2006; 28(3):655-60. View

Han X, Xu K, Taratula O, Farsad K . Applications of nanoparticles in biomedical imaging. Nanoscale. 2019; 11(3):799-819. PMC: 8112886. DOI: 10.1039/c8nr07769j. View

Joniova J, Rebic M, Strejckova A, Huntosova V, Stanicova J, Jancura D . Formation of Large Hypericin Aggregates in Giant Unilamellar Vesicles-Experiments and Modeling. Biophys J. 2017; 112(5):966-975. PMC: 5355495. DOI: 10.1016/j.bpj.2017.01.019. View

Spedalieri C, Szekeres G, Werner S, Guttmann P, Kneipp J . Intracellular optical probing with gold nanostars. Nanoscale. 2020; 13(2):968-979. DOI: 10.1039/d0nr07031a. View

Shao H, Zhang J, Sun Z, Chen F, Dai X, Li Y . Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models. Oncotarget. 2015; 6(16):14247-59. PMC: 4546464. DOI: 10.18632/oncotarget.3679. View

10.

Liu Y, Crawford B, Vo-Dinh T . Gold nanoparticles-mediated photothermal therapy and immunotherapy. Immunotherapy. 2018; 10(13):1175-1188. DOI: 10.2217/imt-2018-0029. View

11.

Shamimi-Noori S, Gonsalves C, Shaw C . Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data. Semin Intervent Radiol. 2017; 34(2):145-166. PMC: 5453777. DOI: 10.1055/s-0037-1602712. View

12.

Mao J, Tang S, Hong D, Zhao F, Niu M, Han X . Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO@(DOX + ILS) drug-loaded microspheres in rabbit VX liver tumours. Nanoscale. 2017; 9(10):3429-3439. DOI: 10.1039/c6nr09862b. View

13.

Mirmalek S, Azizi M, Jangholi E, Yadollah-Damavandi S, Javidi M, Parsa Y . Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line. Cancer Cell Int. 2016; 16:3. PMC: 4748624. DOI: 10.1186/s12935-016-0279-4. View

14.

Qi X, Shao H, Zhang J, Sun Z, Ni Y, Xu K . Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis. Radiol Med. 2014; 120(2):213-21. DOI: 10.1007/s11547-014-0433-9. View

15.

Duong T, Li X, Yang B, Schumann C, Albarqi H, Taratula O . Phototheranostic nanoplatform based on a single cyanine dye for image-guided combinatorial phototherapy. Nanomedicine. 2016; 13(3):955-963. DOI: 10.1016/j.nano.2016.11.005. View

16.

Perrodin S, Lachenmayer A, Maurer M, Kim-Fuchs C, Candinas D, Banz V . Percutaneous stereotactic image-guided microwave ablation for malignant liver lesions. Sci Rep. 2019; 9(1):13836. PMC: 6761186. DOI: 10.1038/s41598-019-50159-3. View

17.

Chansanti O, Jahangiri Y, Matsui Y, Adachi A, Geeratikun Y, Kaufman J . Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT. J Vasc Interv Radiol. 2017; 28(11):1528-1535. DOI: 10.1016/j.jvir.2017.07.008. View

18.

Conde J, Ambrosone A, Sanz V, Hernandez Y, Marchesano V, Tian F . Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano. 2012; 6(9):8316-24. DOI: 10.1021/nn3030223. View

19.

Liu X, Jiang C, Li Y, Liu W, Yao N, Gao M . Evaluation of hypericin: effect of aggregation on targeting biodistribution. J Pharm Sci. 2014; 104(1):215-22. DOI: 10.1002/jps.24230. View

20.

Vu M, Kelly H, Wheatley A, Peng S, Pilkington E, Veldhuis N . Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network. Small. 2020; 16(33):e2002861. PMC: 7361276. DOI: 10.1002/smll.202002861. View